[Human papillomavirus infections in pregnancy].
After an overview on the diffusion and transmission of the Human Papilloma Virus infection, the authors' attention is focused on clinical and therapeutic aspects of the disease. Following the most recent findings on congenital transmission, problems related to prophylaxis and therapy are discussed.
Niccoli
V
V
Istituto di I Clinica Ostetrica e Ginecologica, Università degli Studi di Roma La Sapienza.
Serrao
L
L
D000293:Adolescent; D000328:Adult; D003452:Cryosurgery; D004564:Electrocoagulation; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D053685:Laser Therapy; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000628:therapy; D011033:Podophyllin / Q000627:therapeutic use; D011034:Podophyllotoxin / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000628:therapy; D014238:Trichloroacetic Acid / Q000627:therapeutic use; D014412:Tumor Virus Infections / Q000175:diagnosis / Q000628:therapy
D014238:Trichloroacetic Acid; D011033:Podophyllin; D007372:Interferons; D011034:Podophyllotoxin; D005472:Fluorouracil